Bilici, AhmetÖlmez, Ömer FatihSezer, AhmetÖksüzoğlu, BernaKaplan, Muhammet AliKaradurmuş, NuriÇubukçu, ErdemŞendur, Mehmet Ali NahitAksoy, SercanErdem, DilekBaşaran, GülÇakar, BurcuŞeker, MesutArslan, ÇağataySezgin Göksu, SemaÇiçin, İrfanGümüş, MahmutSelçukbiricik, FatihHarputluoğlu, HakanHelvacı, Kaan2022-11-072022-11-072022Bilici, A., Ölmez, Ö. F., Sezer, A., Öksüzoğlu, B., Kaplan, M. A., Karadurmuş, N. ... Helvacı, K. (2022). Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study). Journal of Clinical Oncology.0732-183X1527-7755https://hdl.handle.net/20.500.12511/9933[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessHER2PATH StudyBreast CancerAnalysis of PathologicConference Object4016Q1000863680302513